These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1181 related items for PubMed ID: 30777522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y, Aikawa A, Itabashi Y, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Kawamura T, Sakai K, Shishido S.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A.
    Transplantation; 2014 Jun 27; 97(12):1247-52. PubMed ID: 24854670
    [Abstract] [Full Text] [Related]

  • 5. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.
    Clin Transpl; 2014 Jun 27; ():171-8. PubMed ID: 26281142
    [Abstract] [Full Text] [Related]

  • 6. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S, Sharma RK, Mayya M, Gupta A, Prasad N, Kaul A, Bhadauria DS.
    Exp Clin Transplant; 2017 Aug 27; 15(4):394-399. PubMed ID: 28447925
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
    Rostaing L, Congy N, Aarnink A, Maggioni S, Allal A, Sallusto F, Game X, Kamar N.
    Exp Clin Transplant; 2015 Apr 27; 13 Suppl 1():201-6. PubMed ID: 25894155
    [Abstract] [Full Text] [Related]

  • 8. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P, Jouve T, Noble J, Rostaing L.
    Exp Clin Transplant; 2018 Aug 27; 16(4):367-375. PubMed ID: 29863455
    [Abstract] [Full Text] [Related]

  • 9. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K, Tsuchimoto A, Kurihara K, Okabe Y, Kitada H, Okumi M, Tanabe K, Nakamura M, Kitazono T, Tsuruya K, Japan Academic Consortium of Kidney Transplantation (JACK) investigators.
    Transplantation; 2017 Jun 27; 101(6):1416-1422. PubMed ID: 27391195
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.
    Hum Immunol; 2013 Sep 27; 74(9):1111-8. PubMed ID: 23792054
    [Abstract] [Full Text] [Related]

  • 12. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K, Saito K, Takahara S, Fuchinoue S, Yagisawa T, Aikawa A, Watarai Y, Yoshimura N, Tanabe K, Morozumi K, Shimazu M, IDEC-C2B8 ABO-I KTx Study Group.
    Clin Exp Nephrol; 2017 Aug 27; 21(4):705-713. PubMed ID: 27534951
    [Abstract] [Full Text] [Related]

  • 13. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K, Süsal C, Schäfer SM, Becker LE, Beimler J, Schwenger V, Zeier M, Schemmer P, Macher-Goeppinger S, Scherer S, Opelz G, Morath C.
    Atheroscler Suppl; 2013 Jan 27; 14(1):199-202. PubMed ID: 23357165
    [Abstract] [Full Text] [Related]

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 15. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A, Özçelik Ü, Ogan Uyanık E, Külah E, Demirağ A.
    Exp Clin Transplant; 2016 Aug 27; 14(4):401-4. PubMed ID: 26517205
    [Abstract] [Full Text] [Related]

  • 16. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK, Cho JH, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan 27; 44(1):200-3. PubMed ID: 22310614
    [Abstract] [Full Text] [Related]

  • 17. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP, Wang CX, Gao W, Fu Q, He XS.
    Exp Clin Transplant; 2010 Jun 27; 8(2):130-5. PubMed ID: 20565369
    [Abstract] [Full Text] [Related]

  • 18. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E, Cravedi P, Martorell J, Luque S, Melilli E, Cruzado JM, Jarque M, Meneghini M, Manonelles A, Donadei C, Lloberas N, Gomà M, Grinyó JM, Heeger P, Bestard O.
    Kidney Int; 2017 Jul 27; 92(1):201-213. PubMed ID: 28274484
    [Abstract] [Full Text] [Related]

  • 19. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
    Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ.
    Ann Am Thorac Soc; 2019 Sep 27; 16(9):1131-1137. PubMed ID: 31026404
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Sep 27; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.